Averell H. Sherker

Gastroenterology
10 Center Dr Bldg 10
Bethesda, MD 20892

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Guideline recommends antiviral prophylaxis for patients at high risk for HBV reactivation.

Guideline recommends antiviral prophylaxis for patients at high risk for HBV reactivation.

Journal: Annals of internal medicine
Published: May 05, 2025

Letter to the Editor: Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease-October 2024 updates to AASLD practice guidance.

Letter to the Editor: Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease-October 2024 updates to AASLD practice guidance.

Journal: Hepatology (Baltimore, Md.)
Published: November 07, 2024

Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury.

Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury.

Journal: Drug safety
Published: September 01, 2024

In NASH with liver fibrosis, resmetirom improved NASH resolution and reduced fibrosis at 1 y.

In NASH with liver fibrosis, resmetirom improved NASH resolution and reduced fibrosis at 1 y.

Journal: Annals of internal medicine
Published: June 03, 2024

Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease.

Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease.

Journal: Hepatology (Baltimore, Md.)
Published: February 10, 2022

In decompensated cirrhosis, targeted albumin infusions did not improve an in-hospital composite outcome at 15 d.

In decompensated cirrhosis, targeted albumin infusions did not improve an in-hospital composite outcome at 15 d.

Journal: Annals of internal medicine
Published: August 02, 2021

Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management.

Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management.

Journal: Hepatology (Baltimore, Md.)
Published: April 28, 2020

Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal Hypertension.

Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal Hypertension.

Journal: The Journal of pediatrics
Published: January 08, 2020

United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts.

United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts.

Journal: Toxicology reports
Published: December 22, 2019

Heterogeneous Liver on Research Ultrasound Identifies Children with Cystic Fibrosis at High Risk of Advanced Liver Disease: Interim Results of a Prospective Observational Case-Controlled Study.

Heterogeneous Liver on Research Ultrasound Identifies Children with Cystic Fibrosis at High Risk of Advanced Liver Disease: Interim Results of a Prospective Observational Case-Controlled Study.

Journal: The Journal of pediatrics
Published: September 30, 2019

A Phase I/IIa Trial of Intravenous Immunoglobulin Following Portoenterostomy in Biliary Atresia.

A Phase I/IIa Trial of Intravenous Immunoglobulin Following Portoenterostomy in Biliary Atresia.

Journal: Journal of pediatric gastroenterology and nutrition
Published: January 22, 2019

Correlation of Immune Markers With Outcomes in Biliary Atresia Following Intravenous Immunoglobulin Therapy.

Correlation of Immune Markers With Outcomes in Biliary Atresia Following Intravenous Immunoglobulin Therapy.

Journal: Hepatology communications
Published: November 30, 2018
Showing 1-12 of 43

Last Updated: 09/26/2026